Frontline brentuximab vedotin plus cyclophosphamide, doxorubicin and prednisone in patients with peripheral T-cell lymphoma with less than 10% CD30 expression (SGN35-032, trial in progress) Meeting Abstract
| Authors: | Jagadeesh, D.; Knowles, S.; Horwitz, S. M. |
| Abstract Title: | Frontline brentuximab vedotin plus cyclophosphamide, doxorubicin and prednisone in patients with peripheral T-cell lymphoma with less than 10% CD30 expression (SGN35-032, trial in progress) |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398805129 |
| DOI: | 10.1182/blood-2021-151645 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1401 -- Hybrid meeting, also took place online -- Source: Wos |
